-transparent.png){kind=logo}
Cell kinetic changes induced in the marrow blasts by treatment with a triple cytotoxic regimen including daunorubicin, cytosine arabinoside and 6-thioguanine (DAT) were investigated in 6 previously untreated acute nonlymphocytic leukemia patients. A decrease in the labeling and mitotic indices was consistently observed 24 h after administration of daunorubicin, suggesting a G2 block and a preferential lytic effect on the S-phase cells operated by the drug. Conversely, cytosine arabinoside and 6-thioguanine in combination induced a series of kinetic perturbations variable from case to case; however, three principal patterns of kinetic response were recogized and discussed in detail. Useful information for the planning of a more rational antileukemic therapy can be drawn from a systematic study of the kinetic effects induced by drug combinations.
S Amadori, and
M C Petti, and
C Mastrovincenzo, and
M G Testa
January 1974,
Bulletin du cancer,
S Amadori, and
M C Petti, and
C Mastrovincenzo, and
M G Testa
January 1979,
Leukemia research,
S Amadori, and
M C Petti, and
C Mastrovincenzo, and
M G Testa
February 1974,
Cancer,
S Amadori, and
M C Petti, and
C Mastrovincenzo, and
M G Testa
January 1984,
Sangre,
S Amadori, and
M C Petti, and
C Mastrovincenzo, and
M G Testa
January 1981,
Cancer clinical trials,
S Amadori, and
M C Petti, and
C Mastrovincenzo, and
M G Testa
September 1977,
Cancer,
S Amadori, and
M C Petti, and
C Mastrovincenzo, and
M G Testa
December 1972,
California medicine,
S Amadori, and
M C Petti, and
C Mastrovincenzo, and
M G Testa
August 1984,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
S Amadori, and
M C Petti, and
C Mastrovincenzo, and
M G Testa
January 1978,
Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
S Amadori, and
M C Petti, and
C Mastrovincenzo, and
M G Testa
November 1975,
Cancer,
